Medicover (MCOV-B.ST) Stock Analysis & AI Equity Report
Medicover (MCOV-B.ST) overview
Medicover (MCOV-B.ST) stock analysis and AI equity research. For the latest completed financial year, 2024, Medicover reported revenue of EUR 2,092m and operating profit of EUR 70.3m; the year-end share price was 192.00 SEK and market capitalisation was SEK 28,827m. Medicover is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Medicover's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2025-09-03. Data will be refreshed during report generation.
About Medicover
Medicover AB (publ) provides healthcare services and diagnostic laboratory testing through two divisions. Healthcare Services offers outpatient and inpatient care, dentistry, fertility treatments, pharmacies, gyms and other wellbeing services, while Diagnostic Services runs laboratories, blood-drawing points and clinics that provide routine and advanced tests across major clinical areas in multiple European markets.
Generate the Medicover report
Medicover is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Medicover and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.